Drug cost avoidance analysis of cancer clinical trials in Spain: a study on cost contributors and their impact

• Principais autores: Domingo Antonio Sánchez Martínez (Autor), Federico Salas-Lucia (Autor), Hanzi Jiang (Autor), Paula Ruiz-Carreño (Autor), José Luis Alonso Romero (Autor)
• Formato: Livro
• Publicado em: BMC, 2022-07-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Objective Analyze the cost contributors and their impact on the drug cost avoidance (DCA) resulting from cancer clinical trials over the period of 2015-2020 in a tertiary-level hospital in Spain (HCUVA). Methods We performed a cross-sectional, observational, retrospective study of a total o...